These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22698077)

  • 41. Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy.
    Zheng M; Lv LL; Cao YH; Zhang JD; Wu M; Ma KL; Phillips AO; Liu BC
    Clin Endocrinol (Oxf); 2012 May; 76(5):657-64. PubMed ID: 21824169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
    Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
    Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
    Marshall CB
    Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).
    Luo Y; Zhang W; Qin G
    Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 38963028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
    Ma R; Liu L; Jiang W; Yu Y; Song H
    Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel biomarkers of diabetic kidney disease: current status and potential clinical application.
    Barutta F; Bellini S; Canepa S; Durazzo M; Gruden G
    Acta Diabetol; 2021 Jul; 58(7):819-830. PubMed ID: 33528734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression.
    Schutte E; Gansevoort RT; Benner J; Lutgers HL; Lambers Heerspink HJ
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv96-104. PubMed ID: 26209744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
    Umezono T; Toyoda M; Kato M; Miyauchi M; Kimura M; Maruyama M; Honma M; Yagame M; Suzuki D
    J Nephrol; 2006; 19(6):751-7. PubMed ID: 17173248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.
    Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G
    J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Early detection of diabetic nephropathy].
    Murussi M; Murussi N; Campagnolo N; Silveiro SP
    Arq Bras Endocrinol Metabol; 2008 Apr; 52(3):442-51. PubMed ID: 18506269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of diabetic nephropathy in the proteomic era.
    Thongboonkerd V
    Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypertrophy and loss of podocytes in diabetic nephropathy.
    Miyauchi M; Toyoda M; Kobayashi K; Abe M; Kobayashi T; Kato M; Yamamoto N; Kimura M; Umezono T; Suzuki D
    Intern Med; 2009; 48(18):1615-20. PubMed ID: 19755763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy.
    Kishore L; Kaur N; Singh R
    Curr Diabetes Rev; 2017; 13(6):598-605. PubMed ID: 27924722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
    J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy.
    Dai H; Liu Q; Liu B
    J Diabetes Res; 2017; 2017():2615286. PubMed ID: 28791309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy.
    Liu N; Xu L; Shi Y; Zhuang S
    J Diabetes Res; 2017; 2017():3560238. PubMed ID: 28512641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of inflammation in diabetic nephropathy.
    Fornoni A; Ijaz A; Tejada T; Lenz O
    Curr Diabetes Rev; 2008 Feb; 4(1):10-7. PubMed ID: 18220690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.